(Q28342707)

Cardiology and cardiovascular medicine

title

Efficacy and safety of sotalol in patients with complex ventricular arrhythmias (English)

0 references

main subject

heart arrhythmia

0 references

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

22 November 2023

author name string

S. H. Hohnloser

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1281807

8 September 2022

M. Zabel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1281807

8 September 2022

A. van de Loo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1281807

8 September 2022

T. Klingenheben

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1281807

8 September 2022

H. Just

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1281807

full work available at URL

8 September 2022

language of work or name

English

0 references

publication date

December 1992

0 references

https://api.elsevier.com/content/article/PII:0167527392902574?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

https://api.elsevier.com/content/article/PII:0167527392902574?httpAccept=text/plain

22 November 2023

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

International Journal of Cardiology

22 November 2023

published in

0 references

volume

37

0 references

issue

3

0 references

page(s)

283-91

0 references

cites work

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors

22 November 2023

2

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy

22 November 2023

3

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Controlled trial of sotalol for one year after myocardial infarction

22 November 2023

5

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Sotalol: a beta blocker with unique antiarrhythmic properties

22 November 2023

6

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexes

22 November 2023

7

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Effects of the beta-adrenoceptor-blocking agent Sotalol on ventricular arrhythmias in patients with chronic ischemic heart disease. A placebo-controlled, double-blind cross-over study

22 November 2023

8

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

A comparison of the efficacy of sotalol and nadolol in the suppression of ventricular ectopic beats

22 November 2023

9

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study

22 November 2023

10

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.

22 November 2023

11

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Concentration-dependent pharmacologic properties of sotalol

22 November 2023

12

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography

22 November 2023

13

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Long-term experience with sotalol in the treatment of complex ventricular arrhythmias

22 November 2023

14

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia

22 November 2023

15

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Relation between ventricular function and antiarrhythmic responses to sotalol

22 November 2023

16

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Sotalol versus class I and II antiarrhythmic agents

22 November 2023

17

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias

22 November 2023

18

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias

22 November 2023

19

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Criteria for the accurate interpretation of changes in left ventricular ejection fraction and cardiac volumes as assessed by rest and exercise gated radionuclide angiography.

22 November 2023

20

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

22 November 2023

21

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents

22 November 2023

26

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Temporal relation between long-lasting aftercontractions and action potentials in cat papillary muscles

22 November 2023

27

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Comparative assessment of?-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: Similarity of inotropic and chronotropic blocking potencies against isoproterenol

22 November 2023

28

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Sudden unexpected death in patients with congestive heart failure: a second frontier

22 November 2023

30

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

22 November 2023

31

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmias

22 November 2023

32

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

Sotalol, hypokalaemia, syncope, and torsade de pointes

22 November 2023

33

1 reference

https://api.crossref.org/works/10.1016/0167-5273(92)90257-4

22 November 2023

Identifiers

0 references